ANNALS OF THE RHEUMATIC DISEASES

Annals of the Rheumatic Diseases (ISSN 0003-4967) is a prestigious monthly journal published by the British Medical Association (BMA) in London, United Kingdom, that serves as a leading platform for high-quality research in rheumatology. As an SCI-indexed publication, it consistently maintains a high impact factor and is typically ranked in the top tier (Zone 1 or 2) of the Chinese Academy of Sciences journal classification for the medical sciences. The journal publishes original research, reviews, and clinical studies that bridge the gap between basic science and clinical practice, focusing on the pathogenesis, diagnosis, and treatment of conditions such as rheumatoid arthritis, osteoarthritis, and systemic lupus erythematosus. While it is not fully open access, it offers hybrid open access options for authors. Known for its rigorous peer-review process and high rejection rate, the journal prioritizes methodological rigor, innovation, and clinical utility, thereby maintaining a strong reputation among researchers and clinicians worldwide.